PMC4217757_01
(a) MRI showed the rectovaginal fistula before administration of infliximab. (b) Barium-enema study showed the barium running into the vaginal cavity before administration of infliximab. White arrows pointed respectively A: rectum; B: rectovaginal fistula; C: J-pouch (atypical bridge); D: vagina cavity.
jocmr-07-059-g001.jpg
PMC4217757_01_jocmr-07-059-g001.jpg
F1
Figure 1 shows the abdominal magnetic resonance imaging (MRI) and barium-enema study of the rectovaginal fistula before starting treatment.
Symptomatic changes (excrement time, CRP, BMI, ERS) after admission in a graph with time dependently as a basic date (day 0) by the infliximab beginning day.
jocmr-07-059-g002.jpg
PMC4217757_01_jocmr-07-059-g002.jpg
F2
Figure 2 shows the time course of the symptomatic changes after the admission.
(a) MRI. (b) Barium-enema study. Both examinations are inspected from the start of therapy 1 year later, and confirmed rectovaginal fistula closing.
jocmr-07-059-g003.jpg
PMC4217757_01_jocmr-07-059-g003.jpg
F3
Figure 3 shows the results of the imaging study 1 year after the start of infliximab therapy.